# Patient-Focused Drug Development: Methods to Identify What Is Important to Patients:  Guidance for Industry, Food and Drug Administration Staff, and Other Stakeholders - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/patient-focused-drug-development-methods-to-identify-what-is-important-to-patients-guidance-for-industry-food-and-drug-administration-staff-and-other-stakeholders/06de176c-365a-43ad-84f7-7aa3926833b5

> FDA guidance document: Patient-Focused Drug Development: Methods to Identify What Is Important to Patients:  Guidance for Industry, Food and Drug Administration Staff, and Other Stakeholders. Issue date: February 25, 2022. Get complete insights and analysis.

---

## Details

- Title: Patient-Focused Drug Development: Methods to Identify What Is Important to Patients:  Guidance for Industry, Food and Drug Administration Staff, and Other Stakeholders
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2022-02-25
- Comment Close Date: 2019-12-30
- Last Changed: 2025-01-31
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2019-D-4247 ">FDA-2019-D-4247 </a>

## Related Documents

- [General Clinical Pharmacology Considerations for Neonatal Studies for Drugs and Biological Products Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/general-clinical-pharmacology-considerations-for-neonatal-studies-for-drugs-and-biological-products-guidance-for-industry/0c57731e-55bc-4962-a619-54444aa22335)
- [Patient-Focused Drug Development:  Collecting Comprehensive and Representative Input](https://www.globalkeysolutions.net/guidances/guidance-document/patient-focused-drug-development-collecting-comprehensive-and-representative-input/abbf838a-9294-4c1b-a0d1-55c963831af5)
- [Drug Product Tracing: The Effect of Section 585 of the FD&C Act](https://www.globalkeysolutions.net/guidances/guidance-document/drug-product-tracing-the-effect-of-section-585-of-the-fdc-act/34847c6a-61d4-4e1e-838f-dad6e160e8c3)